NEUARTIGE PYRAZOLDERIVATE

European patent · EP2964646 · In force

Register entry

Publication number
EP2964646
Application number
EP14709590
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Mar 4, 2014
Published
Jan 13, 2016
Granted
Apr 19, 2017
Protection ends at the latest
Mar 3, 2034
Next annual fee due
Mar 31, 2027
IPC classes
C07D 471/04 (2006.01)
C07D 487/04 (2006.01)
C07D 473/04 (2006.01)
Priority
EP 13158233 07.03.2013
PCT application
PCT/EP2014/054107 04.03.2014
PCT publication
WO2014/135507 12.09.2014
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Apr 1, 2026

    Change

    Published in Swissreg on 01.04.2026

  2. Apr 1, 2025

    Change

    Published in Swissreg on 01.04.2025

  3. Apr 1, 2024

    Change

    Published in Swissreg on 01.04.2024

  4. Apr 1, 2023

    Change

    Published in Swissreg on 01.04.2023

  5. Apr 19, 2017

    Granted

    Published in Swissreg on 19.04.2017

Parties

Holder

F. Hoffmann-La Roche AG

Grenzacherstrasse 124, 4070 Basel

Inventor

GRETHER, Uwe

79588 Efringen-Kirchen, DE

KIMBARA, Atsushi

Chuo-ku Tokyo 103-8324, JP

NETTEKOVEN, Matthias

79639 Grenzach-Wyhlen, DE

RICKLIN, Fabienne

F-68490 Hombourg, FR

ROEVER, Stephan

79594 Inzlingen, DE

ROGERS-EVANS, Mark

CH-4103 Bottmingen

SCHULZ-GASCH, Tanja

CH-4417 Ziefen

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.